Literature DB >> 25894614

Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells.

Jean-Rémi Bertrand1,2,3, Claire Lucas1,2,3, Ngoc Minh Pham1,2,3, Catherine Durieu4, Patrick Couvreur5, Claude Paul Malvy1,2,3, Didier Desmaële5.   

Abstract

Covalent binding of squalene to siRNA has already been shown to be an interesting way of delivering siRNA in vivo. Whether squalene derivatives could also be used to deliver siRNA in cells without covalent binding similar to usual transfection with cationic lipids is the question addressed in this article. Accordingly, we investigated the activity of two squalene derivatives bearing a quaternary ammonium head group and a guanidinium group, respectively. The second derivative displayed interesting properties for delivering siRNA into cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894614      PMCID: PMC4440994          DOI: 10.1089/nat.2014.0504

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  12 in total

1.  EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

Authors:  Alexandre Prieur; Franck Tirode; Pinchas Cohen; Olivier Delattre
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

2.  A novel cationic niosome formulation for gene delivery to the retina.

Authors:  G Puras; M Mashal; J Zárate; M Agirre; E Ojeda; S Grijalvo; R Eritja; A Diaz-Tahoces; G Martínez Navarrete; M Avilés-Trigueros; E Fernández; J L Pedraz
Journal:  J Control Release       Date:  2013-11-11       Impact factor: 9.776

3.  Nanodiamond as a vector for siRNA delivery to Ewing sarcoma cells.

Authors:  Anna Alhaddad; Marie-Pierre Adam; Jacques Botsoa; Géraldine Dantelle; Sandrine Perruchas; Thierry Gacoin; Christelle Mansuy; Solange Lavielle; Claude Malvy; François Treussart; Jean-Rémi Bertrand
Journal:  Small       Date:  2011-09-12       Impact factor: 13.281

4.  Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma.

Authors:  Mouna Raouane; Didier Desmaele; Marie Gilbert-Sirieix; Claire Gueutin; Fatima Zouhiri; Claudie Bourgaux; Elise Lepeltier; Ruxandra Gref; Ridha Ben Salah; Gary Clayman; Liliane Massaad-Massade; Patrick Couvreur
Journal:  J Med Chem       Date:  2011-05-18       Impact factor: 7.446

5.  Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

Authors:  Kevin J Polach; Majed Matar; Jennifer Rice; Gregory Slobodkin; Jeff Sparks; Richard Congo; Angela Rea-Ramsey; Diane McClure; Elaine Brunhoeber; Monika Krampert; Andrea Schuster; Kerstin Jahn-Hofmann; Matthias John; Hans-Peter Vornlocher; Jason G Fewell; Khursheed Anwer; Anke Geick
Journal:  Mol Ther       Date:  2011-10-11       Impact factor: 11.454

Review 6.  Physicochemical characterization techniques for lipid based delivery systems for siRNA.

Authors:  Mamta Kapoor; Diane J Burgess; Siddhesh D Patil
Journal:  Int J Pharm       Date:  2011-09-29       Impact factor: 5.875

7.  Squalenoyl nanomedicines as potential therapeutics.

Authors:  Patrick Couvreur; Barbara Stella; L Harivardhan Reddy; Hervé Hillaireau; Catherine Dubernet; Didier Desmaële; Sinda Lepêtre-Mouelhi; Flavio Rocco; Nathalie Dereuddre-Bosquet; Pascal Clayette; Véronique Rosilio; Véronique Marsaud; Jack-Michel Renoir; Luigi Cattel
Journal:  Nano Lett       Date:  2006-11       Impact factor: 11.189

8.  Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.

Authors:  Manuela Aleku; Petra Schulz; Oliver Keil; Ansgar Santel; Ute Schaeper; Britta Dieckhoff; Oliver Janke; Jens Endruschat; Birgit Durieux; Nadine Röder; Kathrin Löffler; Christian Lange; Melanie Fechtner; Kristin Möpert; Gerald Fisch; Sibylle Dames; Wolfgang Arnold; Karin Jochims; Klaus Giese; Bertram Wiedenmann; Arne Scholz; Jörg Kaufmann
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

9.  Liposomes for use in gene delivery.

Authors:  Daniel A Balazs; Wt Godbey
Journal:  J Drug Deliv       Date:  2010-12-15

10.  Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation.

Authors:  Bettina Ralay-Ranaivo; Didier Desmaële; Elsa P Bianchini; Elise Lepeltier; Claudie Bourgaux; Delphine Borgel; Thierry Pouget; Jean François Tranchant; Patrick Couvreur; Ruxandra Gref
Journal:  J Control Release       Date:  2014-08-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.